Dive Into Dollar Tr...
Health Care: Drugs
Talon Therapeutics Inc. (TLON: OTC)
$0.42 -0.04 | -8.79%
05/17/13 - 03:22 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.42 |
| 52 Week High | 1.83 |
| 52 Week Low | 0.40 |
| Avg. Daily Vol. (Mil) | 0.04 |
| Beta (3 year) | 1.70 |
| Share Related Items | |
| Mkt Cap (Mil) | 9.13 |
| Shares Out (Mil) | 22.01 |
| Float (Mil) | 19.28 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.20 |
| Current Ratio | 0.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 0.00 |
| Price/Cash Flow | -0.20 |
| Per Share Data | |
| Earnings | -2.95 |
| Sales | 0.00 |
| Book Value | 0.00 |
| Cash Flow | -2.20 |
| Business Summary | |
|---|---|
| Talon Therapeutics, Inc. is a biopharmaceutical company, dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. | |
| General Information | |
| 2207 Bridgepointe Parkway
Suite 250 San Mateo, CA 94404 |
|
| www.talontx.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 24 | |
| CEO: Dr. Steven R. Deitcher,M | |
| Short Interest | |
| Current Month (Mil) | 0.26 |
| Previous Month (Mil) | 0.05 |
| Short Interest Ratio (Days) | 4.40 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -1,068.90 |
| Return on Investments | 70.20 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with TLON
- Portfolio NameUser Type
- ContributorDrugs Facing FDA Approval i...
Latest TLON Headlines from TheStreet
- Talon Therapeutics, Inc. Reports Fourth Quarter And Year End 2012 Financial Results 04.01.13 | 09:04 am
- Talon Therapeutics To Host A Conference Call To Report 2012 Financial Results And Business Update On April 1, 2013 03.19.13 | 09:03 am
- Talon Therapeutics Announces Review Of Strategic Alternatives 01.07.13 | 09:01 am
- Talon Therapeutics Appoints Elizabeth Weatherman To Board Of Directors 01.04.13 | 09:01 am
- Talon Therapeutics, Inc. Reports Second Quarter 2012 Financial Results 08.13.12 | 09:08 am
- Talon Therapeutics' Marqibo(R) (vinCRIStine Sulfate LIPOSOME Injection) Granted Accelerated Approval By FDA 08.09.12 | 12:08 pm
- Biotech Stock Mailbag: Mela, Osiris, Talon 08.03.12 | 06:08 am
- 28 Drugs Facing FDA Approval in 2012-2013 07.24.12 | 07:07 am
- Biotech Stock Mailbag: Xoma's Big Backers, FDA Approvals Contest 03.23.12 | 05:03 am
- Talon Therapeutics: FDA Panel Live Blog 03.21.12 | 07:03 am
Press Releases for TLON
Partner Headlines for TLON
